Sweden begins mass vaccinations against swine flu
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.(AFP)
Sweden began inoculations against swine flu on Monday, kicking off a mass vaccination campaign that it is offering to its entire population, officials said.
Health care staff at Malmoe University Hospital in southern Sweden were the first to receive their vaccinations, hospital officials told AFP.
Other clinics and hospitals around the country were to begin offering the shots later this week or early next week, with health care workers and pregnant women given priority, public health authorities said.
The Swedish government has set aside one billion kronor (100 million euros, 142 million dollars) to help pay for the vaccination of its entire population against the A(H1N1) virus.
The vaccinations are thus free of charge to patients.
Recent surveys have shown that between 50 and 70 percent of Swedes plan to vaccinate themselves, but health care authorities have said a figure closer to 80 percent is necessary to prevent the spread of a second wave of the pandemic.
The Scandinavian country has registered two deaths from swine flu.
Sweden bought 18 million doses of the vaccine from British pharmaceutical giant GlaxoSmithKline, enough to provide its population of some 9.3 million people with two doses each if necessary.
po/lth
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments